The overall mission of the Global Research Awards for Nicotine Dependence (GRAND) program is to advance the understanding of the mechanisms of tobacco and nicotine dependence and their treatment. The application period for GRAND 2013 was from April 22 to July 2, 2013. Applications for 2013 are now closed. Please check back in early 2014 to see whether a GRAND program for 2014 has been announced.
The GRAND program will fund at least 5 grants of between US $50,000 and US $200,000 in value, totaling US $1 million. In 2013, 6 awards were granted. For details of the winning applications, please click here.
Scope of the Program for 2013
Research projects should aim to provide information that could directly advance the use of pharmacotherapy in clinical practice
Examples could include:
- Optimization of the use of currently available medication
- Effectiveness of treatment in real-life
- Development or use of new medications
- Combinations of medication and counseling
- Specifically designed interventions in subtypes of smokers or smokeless tobacco users
- Use of existing databases to inform the clinical use of pharmacotherapy.
Non-human studies and educational programs fell outside of the scope of the GRAND program for 2013 and were not considered for an Award
Examples of other topics that fell outside of the scope of the GRAND program for 2013 and were not considered for an Award, unless directly related to advancing the use of pharmacotherapy, included:
- Tobacco Policy.